To further assess the applicability of this method to produce and purify high-value therapeutic proteins, we targeted three first-line anti-cancer therapeutic proteins including human tumor necrosis factor alpha (TNFα), human granulocyte colony-stimulating factor (G-CSF), and human interferon alpha 2b (IFNα2b). This evidence concerns the gene TNF and cancer.